Published in Br J Pharmacol on December 01, 2012
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Microglia during development and aging. Pharmacol Ther (2013) 1.30
Activation of GPR18 by cannabinoid compounds: a tale of biased agonism. Br J Pharmacol (2014) 0.94
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice. EMBO Mol Med (2014) 0.89
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol Pharmacol (2012) 0.88
The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure. J Pharmacol Exp Ther (2014) 0.84
Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics (2015) 0.79
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. Front Pharmacol (2014) 0.78
N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs. Br J Pharmacol (2013) 0.78
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures. Neural Plast (2015) 0.77
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18. Sci Rep (2016) 0.75
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol (2016) 0.75
2012 cannabinoid themed section. Br J Pharmacol (2012) 0.75
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J (1999) 6.25
Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci (2009) 4.83
Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol (1990) 4.37
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res (1998) 3.94
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54
The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A (2003) 3.24
Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell (2008) 3.19
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci (2003) 2.84
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem (2001) 2.19
Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids (2002) 2.15
Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci (2001) 2.08
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem (1997) 2.01
Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J (2006) 2.01
Evidence for novel cannabinoid receptors. Pharmacol Ther (2005) 2.00
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol (2003) 1.95
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun (2006) 1.79
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci (2010) 1.78
Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab (2007) 1.71
Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res (1988) 1.36
Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience (1990) 1.35
Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett (1988) 1.35
Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J Biol Chem (2006) 1.32
Mice as models: transgenic approaches and Alzheimer's disease. J Alzheimers Dis (2006) 1.32
Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol (2012) 1.31
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol (2005) 1.23
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol (2003) 1.20
Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol (2005) 1.18
Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci (2004) 1.16
Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr Allergy Asthma Rep (2003) 1.14
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol (2004) 1.12
Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis. Genomics (1997) 1.12
Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev (2001) 1.11
Novel endogenous N-acyl glycines identification and characterization. Vitam Horm (2009) 1.09
Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res (2010) 1.08
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Neurobiol Dis (2007) 1.05
Development and characterization of an experimental model of brain abscess in the rat. Am J Pathol (1992) 0.99
Resolution of inflammation by N-arachidonoylglycine. J Cell Biochem (2011) 0.96
Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol Dis (1999) 0.94
Mouse model for ablation of proliferating microglia in acute CNS injuries. Glia (2006) 0.93
N-arachidonoyl glycine induces macrophage apoptosis via GPR18. Biochem Biophys Res Commun (2012) 0.91
Wallerian degeneration induces Ia-antigen expression in the rat brain. J Neuroimmunol (1989) 0.88
So what do we call GPR18 now? Br J Pharmacol (2012) 0.87
Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience (2005) 0.87
Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol Aging (2000) 0.87
Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res (2006) 0.87
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol (2012) 0.85
Degeneration of optic axons induces the expression of major histocompatibility antigens. Brain Res (1989) 0.85
Kinetics of the cellular immune response following closed head injury. Acta Neurochir (Wien) (2007) 0.85
Response of microglial cells to experimental rat glioma. Glia (1992) 0.81